ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Psychosocial Factors Associated with Medication Adherence Based on Self Reports in Kidney Allograft Recipients: Baseline Findings from the PRIMA (ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application) Study.

    A. Han,1 C. Choi,1 S.-Y. Kim,1 S. Cho,1 M.-J. Cho,1 C. Lee,1 S. Ahn,1 S.-I. Min,1 S.-K. Min,1 I. Jung,1 S. Kim,2 M. Park,3 J. Ha.1,3

    1Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Department of Surgery, Myongji Hospital, Goyang-si, Gyeonggi-do, Republic of Korea; 3Korean Organ Donation Agency, Seoul, Republic of Korea.

    Background. We have assessed the prevalence of medication nonadherence after kidney transplantation and investigated its psychosocial correlates, as a part of the PRIMA study, an…
  • 2016 American Transplant Congress

    Sofosbuvir-Based Regimen in Treatment Experienced-Post Liver Transplant Patients with Hepatitis C Recurrence.

    A. Ajlan,1 A. Aljedai,1 H. Elsiesy,2 D. Alkortas,1 R. Alarieh,2 W. Alhumodi,2 D. Broring,2 M. Alsebayel,2 F. Aba Alkhail.2

    1Pharmaceutical Care, KFSHRC, Riyadh, Saudi Arabia; 2Liver and Small Bowel Transplant, KFSHRC, Riaydh, Saudi Arabia.

    This is an open label, prospective, interventional cohort study conducted at a tertiary referral center. The primary end point is SVR12 in patients treated with…
  • 2016 American Transplant Congress

    The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

    A. Bushell,1 J. van der Net,1,2 D. Game,3 R. Hilton,3 S. Thirkell,4 P. Friend,2 E. Geissler,5 K. Wood,1 P. Harden,2 G. Lombardi.4

    1Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom; 2Oxford Transplant Centre, Oxford, United Kingdom; 3Guy's Hospital, London, United Kingdom; 4Immunoregulation Laboratory, King's College London, Guy's Hospital, London, United Kingdom; 5Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

    Introduction: The UK ONE Study trial investigates the safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation.Materials and Methods: Eleven (9m;2f) living…
  • 2016 American Transplant Congress

    First Clinical Experience with Belatacept in 3 Hand Transplanted Patients.

    J. Grahammer,1 B. Zelger,2 B. Zelger,3 M. Ninkovic,1 A. Muehlbacher,4 D. Oefner-Velano,1 S. Schneeberger,1 A. Weissenbacher.5

    1Viceral, Thoracic and Transplant Surgery, Innsbruck Medical University, Innsbruck, Austria; 2Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria; 3Pathology, Innsbruck Medical University, Innsbruck, Austria; 4Department of Blood Group Serology and Transfusion Medicine, Innsbruck Medical University, Innsbruck, Austria; 5Oxford Transplant Centre, Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom.

    Study purposeBelatacept (CTLA4Ig) is an emerging treatment in solid organ transplantation. Effects on the development of donor specific antibodies (DSA) as well as its clinical…
  • 2016 American Transplant Congress

    Long Term Outcome of De-Novo Autoimmune Hepatitis in Pediatric Recipients of Liver Transplantation.

    Y. Avitzur,1 P. McKiernan,2 M. Martinez,3 S. Lobritto,3 D. Kelly,2 V. Ng,1 E. Alonso,4 U. Ekong.5

    1Hospital for Sick Children, Toronto, Canada; 2Birmingham Children's Hospital, Birmingham, United Kingdom; 3Morgan Stanley Children's Hospital, New York; 4Lurie Children's Hospital, Chicago; 5Yale New Haven Children's Hospital, New Haven.

    Background: De-novo autoimmune hepatitis (DAIH) is a chronic immune mediated graft disorder seen following liver transplantation (LT). The long-term course and outcome of DAIH is…
  • 2016 American Transplant Congress

    Peer Mentoring to Improve Access to Kidney Transplantation in the Southeast.

    J. Gander,1 S. McMath,2 M. Rudd,2 L. Sauls,3 S. Tripathi,1 L. Plantinga,1 L. McPherson,1 T. Browne,4 S. Pastan,1 R. Patzer.1

    1Emory University, Atlanta; 2Georgia Transplant Foundation, Atlanta; 3ESRD Network 6, Raleigh; 4University of South Carolina, Columbia.

    BACKGROUND The Southeastern Kidney Transplant Coalition's (SEKTC) mission is to improve the low kidney transplantation (KTx) rate in the North Carolina, South Carolina, and Georgia.…
  • 2016 American Transplant Congress

    Share35 Liver Allocation Is Associated with Increased Early Graft Failure Rate.

    T. Wong,1 N. Koizumi,2 J. Ortiz.3

    1Maricopa Medical Center, Phoenix, AZ; 2George Mason University, Arlington, VA; 3University of Toledo, Toledo, OH.

    Background: The implementation of Share35 liver allocation policy in June 2013 facilitated the increase in number of transplanted livers with less organ discards. Early analysis…
  • 2016 American Transplant Congress

    Incidence and Indications for Pancreatectomy After Late Pancreas Allograft Failure.

    S. Parajuli, A. Djamali, B. Astor, H. Sollinger, D. Kaufman, R. Redfield, J. Odorico, D. Mandelbrot.

    University of Wisconsin School of Medicine and Public Health, Madison, WI.

    There is little information about incidence, indications and risk factors for late allograft pancreatectomy (PTX) in patients with ongoing immunosuppression for a functional kidney allograft.We…
  • 2016 American Transplant Congress

    The Treatment of Borderline Lesion in Protocol Biopsies Did Not Improve the Outcome in Kidney Transplant Recipients.

    A. Flores-Mendoza, L. Marino-Vazquez, A. Guichard-Romero, N. Uribe-Uribe, R. Rivera-Marfil, A. Nuñez-Abreu, J. Alberu, L. Morales-Buenrostro.

    Nephrology, Transplantation and Pathology, National Institute of Medical Sciences and Nutrition SZ, Mexico, Distrito Federal, Mexico.

    Introduction. Up to 30% of patients with protocol biopsies and stable renal function have borderline lesions. His relationship with acute rejection remains uncertain, as does…
  • 2016 American Transplant Congress

    Center-Level Variation in Association Between Early Hospital Readmission and Survival Following Kidney Transplantation.

    S. Cramm, E. King, D. Segev.

    Department of Surgery, Johns Hopkins, Baltimore.

    Background: Early hospital readmission (EHR) following kidney transplantation (KT) is associated with inferior survival. However, incidence of EHR varies significantly across center following KT. Recent…
  • « Previous Page
  • 1
  • …
  • 177
  • 178
  • 179
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences